Pro Medicus Limited (ASX:PME) has announced that its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 7-year contract valued at A$23 million with St. Luke's Health System, headquartered in Boise, Idaho, for the deployment of its cloud-based Visage 7 Enterprise Imaging Platform across three states.
Key Points
- 7-year, A$23 million contract signed with St. Luke's Health System, spanning three states
- Contract covers Visage 7 Viewer and Visage 7 Workflow, to be implemented in the cloud
- Agreement is based on a transactional licensing model with potential upside
- Go-live targeted for Q1 in the 2027 calendar year
Contract Terms and Scope
The contract is based on a transactional licensing model and will see Pro Medicus's cloud-based Visage 7 Enterprise Imaging Platform, including Visage 7 Viewer and Visage 7 Workflow, implemented throughout St. Luke's Health System. The agreement is designed to provide St. Luke's with a single, unified enterprise imaging platform. The rollout will be executed by Visage Imaging, Inc., the wholly-owned U.S. subsidiary of Pro Medicus, using Visage's cloud-based implementation process. Planning for the rollout is to commence immediately, according to the company's filing.
St. Luke's Health System Profile
St. Luke's Health System is described in the filing as Idaho's largest private employer and not-for-profit healthcare provider. Its flagship facility, St. Luke's Boise Medical Center, is part of a health system that spans 10 medical centers, including St. Luke's Children's Hospital. St. Luke's provides community-based care to patients across southern Idaho, eastern Oregon, and northern Nevada, according to the filing. The health system is categorised by Pro Medicus as a large to mid-sized integrated delivery network (IDN).
Implementation Timeline and Platform Deployment
According to the filing, planning for the implementation is set to begin immediately and will follow Visage's established cloud-based implementation process. Go-live for the Visage 7 platform at St. Luke's Health System is targeted for the first quarter of the 2027 calendar year. Pro Medicus CEO Dr Sam Hupert was quoted in the filing stating that the company's pipeline remains strong and spans all market segments, from tier 1 academic medical centers through to large and mid-sized IDNs as well as private imaging groups.





_11_18_2026_12_41_48_650646.jpg)
Please wait processing your request...